In the face of shifting consumer health trends, Novo’s online direct-to-patient pharmacy NovoCare has adapted in turn with a major rebrand that expands the platforms services to meet patient needs beyond an initial Wegovy prescription.
The new support program makes for a “reimagined consumer experience,” Novo said in a Nov. 17 press release. Along with home delivery for weight loss med Wegovy, Novocare users can access treatment information and coaching through a free membership and an updated website and app.
"We're helping people get started on treatment and stay supported with tools and resources that go well beyond the prescription, even as their needs evolve,” Novo’s SVP of marketing and patient solutions Ed Cinca explained in a statement. “This is just the beginning of how we show up for the people we serve, with more partners and services to come."
To support patients through the lifestyle changes that comes with a weight loss journey, Novocare is partnering with other brands and services that can help people navigate changes in diet, style and health habits. So far, members can connect with wearable fitness band Whoop, nutrition platform Berry Street, prepared meal service Factor and personalized style site Stitch Fix through Novocare, with “additional partners planned over time,” according to Novo.
The program also offers progress tracking tools and personalized support, helping Wegovy users “keep building your momentum through phases of your weight loss,” the website says.
Soon, those who use commercial or government insurance such as Medicare Bridge will also be able to use Novocare’s home delivery service, expanding its reach beyond the current offerings for those who self-pay for their meds. The program will “look at a person's insurance coverage and show available options” whether it be self-pay or through insurance, Novo said. Also coming soon is a points program that allows users to rack up points through “select activities” that they can use toward offerings from participating partners.
“Novocare will continue to expand, bringing together treatment access, support, information and practical resources to help people navigate care and everyday routines as their needs change,” the company pledged.
While the expanded program is geared toward obesity med Wegovy specifically, the online pharmacy will continue to provide home delivery for eligible prescriptions of diabetes GLP-1 Ozempic, as well as cost and coverage information for other non-obesity Novo drugs, it said.
DTC care programs, telehealth platforms and online pharmacies have been adopted by big drugmakers in droves as the industry chases the trend of healthcare consumerization largely brought on by popular GLP-1s. Companies such as Noom have already jumped on the holistic health wagon by pairing weight loss services, including prescription drug offerings, with behavioral health features including wearable devices and personalized coaching.
With Novocare, the company wants to present a “true one-stop shop” to support both HCPs and patients, Cinca said at HLTH 2026 on Tuesday. Helping patients to navigate side effects and the step-by-step titration schedule they must stick to while adjusting to Wegovy usage is something that “requires a lot of time” from healthcare professionals, he explained.
“There’s a lot of education and there’s a lot of misinformation,” Cinca said. “We want to be this hub for real, correct information for the individuals and then at the same time, help and support them on their journey to higher titration and even greater weight loss.”
Meanwhile, HCPs can also trust that their patients can receive authentic, FDA-approved Wegovy upon sending prescriptions to Novocare, something that “is so important in this day and age,” Cinca added. “They’re going to have the confidence to send their prescription there, and then furthermore know that the patient will ultimately receive the lowest out-of-pocket cost if they're covered by commercial insurance.”
Novo’s oral Wegovy has locked down over eight million prescriptions in the span of ten months, Cinca shared. The company has recently amped up its marketing efforts for the obesity medicine, most recently partnering with Wegovy user DJ Khaled to platform his experience losing weight on the drug.